Eye on FDA

DECEMBER 15, 2021

We are long gone from the days of being threatened by a rampant Alpha virus to having several successive variants. We now have multiple vaccines – mRNA and traditional in the U.S. However there is also an alarming rise among people who have completed their primary vaccination. and an even greater array outside the U.S.

Vaccine 72

Vaccine Nurses Virus Treatment 72

The Pharma Data

JANUARY 11, 2021

health officials raced to ramp up the delivery of COVID-19 vaccines across the country as both coronavirus case counts and death tallies continued to hit record highs. “We really need to get this vaccine out more quickly, because this is really our only tool,” Dr. Scott Gottlieb, former commissioner of the U.S. .

Vaccine 52

Vaccine Virus Assisted Living Nurses 52

The Pharma Data

JANUARY 12, 2021

“Tackling the COVID-19 pandemic will require a combination of public health measures, vaccines and therapeutics. “Additionally, as expected, the virus continues to mutate, with the possibility of developing resistance to any one antibody. . Definition of High-Risk Patients. Schleifer , M.D., ” The U.S.

Government 52

Government Hospitals Virus Production 52

The Pharma Data

NOVEMBER 20, 2020

“The casirivimab and imdevimab antibody cocktail is designed to mimic what a well-functioning immune system does by using very potent antibodies to neutralize the virus,” said George D. Definition of High-Risk Patients. Yancopoulos, M.D., President and Chief Scientific Officer of Regeneron. Have chronic kidney disease.

Therapies 52

Therapies FDA Clinical Trials Hospitals 52

The Pharma Data

NOVEMBER 21, 2020

.” “REGEN-COV2 is designed to mimic what a well-functioning immune system does by using very potent antibodies to neutralize the virus,” said George D. Definition of High-Risk Patients. Yancopoulos , M.D., President and Chief Scientific Officer of Regeneron. Have chronic kidney disease. Have diabetes.

FDA 40

FDA Clinical Trials Hospitals Government 40

The Pharma Data

DECEMBER 18, 2020

Food and Drug Administration said Thursday night that it will move quickly to authorize the emergency use of Moderna’s coronavirus vaccine after one of its advisory panels voted to give its blessing to the shot. “Following today’s positive advisory committee meeting outcome regarding the Moderna COVID-19 vaccine, the U.S.

Vaccine 52

Vaccine FDA Government Hospitals 52

The Pharma Data

DECEMBER 21, 2020

experts announced Sunday which Americans will be next in line receive a COVID-19 vaccine, health officials worldwide worried about a new strain of coronavirus that appears to spread faster than before. The two latest groups in line for a vaccine number roughly 50 million. The new COVID-19 vaccines target that spiky protein.

Vaccine 52

Vaccine Government Hospitals FDA 52